The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.
Moderna's updated Spikevax shot includes 25 µg of spike protein mRNA from BA.4/BA.5 and 25 µg from the original strain of SARS-CoV-2, and has been authorised for the over-18s. It has also been ...
The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.
In part B, the researchers noted that baseline GMTs and day 29 geometric mean fold-rises for nAbs against RSV-A, RSV-B, and SARS-CoV-2 (ancestral and Omicron) were generally similar between ...
Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four major illnesses.
14d
What to Expect on MSNShould You Get the COVID-19 Vaccine for Your Baby or Toddler?Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.
11d
Hosted on MSNMontana Considers Becoming First US State To Ban mRNA Vaccine UseOn Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...
In part B, the researchers noted that baseline GMTs and day 29 geometric mean fold-rises for nAbs against RSV-A, RSV-B, and SARS-CoV-2 (ancestral and Omicron) were generally ... This study was ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, a person close to the matter told Fierce Pharma. The layoffs are ...
In 2024’s fourth quarter, Moderna’s cost of sales came out to $739 million, including $193 million in inventory write-downs and production wind-down costs of $259 million. In that latter ...
Moderna secures a multi-year agreement to supply its COVID-19 vaccine to 17 European countries, including Norway and North Macedonia. Vaccine formats include prefilled syringes, reducing ...
Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results